Molecular imaging spoils mystery of listeriosis
With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.
With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.
As anyone in France knows, pasteurization ruins the flavor of the 500 varieties of cheese manufactured there. The government accepts as a matter of course that a few French people will die every year after eating cheese infected with Listeria, the bacterial cause of listeriosis. (The USDA requires pasteurization for this reason.)
The Pasteur Institute has studied the bacterium for more than 70 years without definitively identifying which organ serves as its central point of habitation. Using recombinant gene technology, Hardy and colleagues introduced the gene for firefly luciferase into the DNA of the bacterium to allow noninvasive tracking with bioluminescent optical imaging in mice. He reportedly had no trouble persuading the mice to eat the subject of his investigation.
Hardy found that Listeria does its deadly work from the gallbladder, whose toxic bile contents were thought to kill bacteria. He presented the study at the 2005 Society of Molecular Imaging meeting in Cologne, Germany.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
